About this item:

910 Views | 1,014 Downloads

Author Notes:

Correspondence: Dong M. Shin, M.D. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd. Building C. Room C3094. Atlanta, GA 30322, USA. Telephone: 1-404-778-2980. Fax: 1-404-778-5520. Email: dmshin@emory.edu.

Acknowledgments: We thank Dr. Anthea Hammond for her critical reading of the manuscript.

Subjects:

Research Funding:

This work was supported by National Cancer Institute (NCI) Specialized Program of Research Excellence (SPORE) grant (P50CA128613) to D.M. Shin and Centers of Cancer Nanotechnology Excellence (CCNE) grant (U54 CA119338) to D.M. Shin and Z.G. Chen.

Keywords:

  • Nanoparticels
  • Cancer therapy
  • Drug delivery

Advances of Cancer Therapy by Nanotechnology

Tools:

Journal Title:

Cancer Research and Treatment

Volume:

Volume 41, Number 1

Publisher:

, Pages 1-11

Type of Work:

Article | Final Publisher PDF

Abstract:

Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient drug targeting and delivery. Clinical investigations suggest that therapeutic nanoparticles can enhance efficacy and reduced side effects compared with conventional cancer therapeutic drugs. Encouraged by rapid and promising progress in cancer nanotechnology, researchers continue to develop novel and efficacious nanoparticles for drug delivery. The use of therapeutic nanoparticles as unique drug delivery systems will be a significant addition to current cancer therapeutics.

Copyright information:

© 2009 Korean Cancer Association. Open Access

Export to EndNote